Navigation Links
Educating the Market: Creating Value Through Support of Continuing Medical Education
Date:2/24/2009

CHAPEL HILL, N.C., Feb. 24 /PRNewswire/ -- Though the American Medical Association and others have called for greater transparency surrounding pharmaceutical industry funding of CME and though some big pharma companies have recently moved to better define funding protocol (one even eliminating funding for CME by third-party vendors), 75 - 100 percent of CME programming at most medical associations and teaching hospitals is funded by the bio-pharma industry. As one interviewed VP put it: "No one else will or can support [CME]."

"Educating the Market: Creating Value Through Support of Continuing Medical Education," a just-published benchmarking report from Best Practices, LLC, explores the changing CME landscape in Europe and North America. The research contained in this report examines not only current CME debates in structuring, standardization, and accreditation, but also shows how new delivery methods like E-CME are transforming the face of Continuing Medical Education around the world.

Now available at http://www3.best-in-class.com/rr981.htm, this new 2009 study's sample findings include:

  • Seventy-four percent of study participants report decreased funding in the past two years and 100% of partners forecast a decrease in funding going forward.
  • A majority of benchmark companies (68%) utilize a decentralized function for CME management or oversight, with 36% involving independent oversight per region and 32% local oversight per country. Although only 29% of benchmark companies employ a centralized structure, those that do reported significant impact through increased leverage of budgets and headcounts.
  • In Europe, 61% of CME is functionally managed by Marketing, as compared to just 26% in North America.
  • Face-to-Face delivery forms predominate in both North America (50.4%) and
  • Europe (65.4%). Enduring Materials deliver just under 20% of CME in both continents.
  • E-CME delivery is more than twice as prevalent in North America (23.9%) than Europe (10.9%).

The leading practices, managerial insights and benchmark metrics in "Educating the Market: Creating Value Through Support of Continuing Medical Education" are drawn from interviews and benchmarking surveys with 30 CME leaders from 26 pharmaceutical and biotechnology companies in both Europe and North America. The research also contains quantitative data and insights from seven third-party CME vendors and eight medical associations and teaching hospitals.

A complimentary summary of "Educating the Market: Creating Value Through Support of Continued Medical Education" is available at http://www3.best-in-class.com/rr981.htm. For more information, contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or ctew@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 18 years; our clients include 48 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pennsylvania Patient Safety Authority Launches New Website and Design With New Tagline Analyzing, Educating and Collaborating for Patient Safety
2. Educating the Market: Creating Value through Support of Continuing Medical Education
3. AUDIO from Medialink and the National Alliance for Hispanic Health: Educating the Hispanic Community About ADHD
4. Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets
5. Frost & Sullivan to Host Analyst Briefing on the European Orphan Diseases Market: Niche-Busters - An Attractive Future?
6. HealthCentral Acquires Wellsphere Creating the Largest Organically Driven Online Health and Wellness Communities
7. Health IT Can Play an Essential Role in Stimulating the Economy and Creating Jobs
8. Massive Cuts to Medicare Home Oxygen Therapy Benefit Taking Effect January 1 Creating Acute Anxiety Among Beneficiary and Provider Communities
9. Leaders at Henry Ford Health System and Memorial Hermann Healthcare System Awarded for Commitment to Creating Safer, More Transparent Environments for Patients
10. Creating Brand Advocates by Delivering the Superior Total Customer Experience
11. Engineer creating more sensitive, safer landmine detectors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... Therapy continues to prove the safety and efficacy of HBOT in treating and ... across the US, points to research showing the similarities of the wounds to ...
(Date:8/23/2017)... TX (PRWEB) , ... August 23, 2017 , ... ... in the healthcare industry, made the 2017 Inc. 5000 with a three-year ... of the nation’s fastest-growing private companies and comprises the most comprehensive look at ...
(Date:8/23/2017)... ... August 23, 2017 , ... MobilityWorks ®, ... named to the 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private ... of 139 percent, marking the twelfth year that the company has been included ...
(Date:8/23/2017)... ... 23, 2017 , ... A new literature review ... points out that therapeutic modalities (physical therapy) is an important part of the ... a wider scope of physical therapy options is showing promising results and supports ...
(Date:8/22/2017)... ... August 22, 2017 , ... The old adage ... as simple as eating healthy foods. But this well-known piece of nutrition advice ... or breaking apart carbohydrates—depends not only on properties of the food but also ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan residents. Naloxone is available ... retail pharmacy, G-3320 Beecher Road. ... and Drug Administration, is intended to block or reverse ... and loss of consciousness. The medication is often carried ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
Breaking Medicine Technology: